Research Grade Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322)

Catalog No.	HS856226
Host species	Human
Species reactivity	Human
Form	Liquid
Purity	>95% purity as determined by SDS-PAGE.
Clonality	Monoclonal
Isotype	IgG-VHH
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target	Interleukin-17A, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, IL17A, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tumor necrosis factor membrane form, N-terminal fragment, NTF, Intracellular domain 1, ICD1, Intracellular domain 2, ICD2, C-domain 1, C-domain 2, Tumor necrosis factor soluble form, TNF
Purification	Protein A/G purified from cell culture supernatant.
Endotoxin level	Please contact the lab for this information.
Expression system	Mammalian Cells
Accession	Q16552 & P01375
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternative name	COVA 322, COVA-322
Clone ID	COVA322
Note	For research use only. Not suitable for clinical or therapeutic use.

Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322) (HS856226) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.

Highlights

●Research Grade — For PK/PD studies, assay development, and ADA research.
●Native Glycosylation — Mammalian expression ensures native-like patterns.